Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19780860rdf:typepubmed:Citationlld:pubmed
pubmed-article:19780860lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:19780860lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:19780860lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:19780860lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:19780860lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:19780860lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:19780860lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:19780860lifeskim:mentionsumls-concept:C0002783lld:lifeskim
pubmed-article:19780860lifeskim:mentionsumls-concept:C0023981lld:lifeskim
pubmed-article:19780860pubmed:issue3lld:pubmed
pubmed-article:19780860pubmed:dateCreated2010-2-17lld:pubmed
pubmed-article:19780860pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19780860pubmed:abstractTextHuman leukocyte antigen (HLA)-B(*)5701 is strongly associated with developing a hypersensitivity reaction to abacavir (ABC) in White and Hispanic subjects. Across the UK, limited data exist on HLA-B(*)5701 prevalence in HIV-1-infected subjects. We determined HLA-B(*)5701 prevalence in the general HIV-1-infected population and in specific ethnic groups, particularly Black Africans who, in general, exhibit greater genetic diversity. We also compared HLA-B(*)5701 results obtained from local laboratories with those from a central provider.lld:pubmed
pubmed-article:19780860pubmed:languageenglld:pubmed
pubmed-article:19780860pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19780860pubmed:citationSubsetIMlld:pubmed
pubmed-article:19780860pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19780860pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19780860pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19780860pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19780860pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19780860pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19780860pubmed:statusMEDLINElld:pubmed
pubmed-article:19780860pubmed:monthMarlld:pubmed
pubmed-article:19780860pubmed:issn1468-1293lld:pubmed
pubmed-article:19780860pubmed:authorpubmed-author:RiceLLlld:pubmed
pubmed-article:19780860pubmed:authorpubmed-author:JacksonFFlld:pubmed
pubmed-article:19780860pubmed:authorpubmed-author:SadiqS TSTlld:pubmed
pubmed-article:19780860pubmed:authorpubmed-author:OrkinCClld:pubmed
pubmed-article:19780860pubmed:authorpubmed-author:UK EPI teamlld:pubmed
pubmed-article:19780860pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19780860pubmed:volume11lld:pubmed
pubmed-article:19780860pubmed:ownerNLMlld:pubmed
pubmed-article:19780860pubmed:authorsCompleteYlld:pubmed
pubmed-article:19780860pubmed:pagination187-92lld:pubmed
pubmed-article:19780860pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:meshHeadingpubmed-meshheading:19780860...lld:pubmed
pubmed-article:19780860pubmed:year2010lld:pubmed
pubmed-article:19780860pubmed:articleTitleProspective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B*5701 in HIV-1-infected UK subjects.lld:pubmed
pubmed-article:19780860pubmed:affiliationDepartment of Infection and Immunity, Barts & the London NHS Trust, London, UK.lld:pubmed
pubmed-article:19780860pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19780860pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19780860lld:pubmed